Close Menu

NEW YORK – The GenomeWeb Index rose more than 4 percent in November, continuing the positive trend it exhibited in September and October. This month, however, the index underperformed the broader markets, which swung sharply upward in reaction to positive news from Pfizer and Moderna on their coronavirus vaccine trials.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.